Effective treatments for pain in the older patient

Paul J. Christo; Sean Li; Stephen J. Gibson; Perry Fine; Haroon Hameed

doi:10.1007/s11916-010-0164-0

Effective treatments for pain in the older patient

Paul J. Christo
, Sean Li
, Stephen J. Gibson
, Perry Fine
, Haroon Hameed

School of Medicine

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

By 2050, the number of older persons across the globe will exceed the number of younger people for the first time in history. Chronic conditions, especially pain, will rise in prevalence as the population ages. Controlling pain in this unique subset of the population demands careful attention to pharmacokinetic and pharmacodynamic factors and their specific impact on pharmacotherapies, relevant complementary and alternative medicine therapies, and interventional strategies.

Original language	English (US)
Pages (from-to)	22-34
Number of pages	13
Journal	Current pain and headache reports
Volume	15
Issue number	1
DOIs	https://doi.org/10.1007/s11916-010-0164-0
State	Published - Feb 2011

Keywords

Aging
Analgesia
Biopsychosocial
Complementary and alternative medicine
Elderly
Geriatric pain
Injections
Interventional techniques
Kyphoplasty
Nerve blocks
Neuromodulation
Older adults
Opioids
Pain control
Pharmacotherapy
Seniors
Vertebroplasty

ASJC Scopus subject areas

Clinical Neurology
Anesthesiology and Pain Medicine

Access to Document

10.1007/s11916-010-0164-0

Cite this

@article{2ee0f6a975ef4d048662e78bb16223ad,

title = "Effective treatments for pain in the older patient",

abstract = "By 2050, the number of older persons across the globe will exceed the number of younger people for the first time in history. Chronic conditions, especially pain, will rise in prevalence as the population ages. Controlling pain in this unique subset of the population demands careful attention to pharmacokinetic and pharmacodynamic factors and their specific impact on pharmacotherapies, relevant complementary and alternative medicine therapies, and interventional strategies.",

keywords = "Aging, Analgesia, Biopsychosocial, Complementary and alternative medicine, Elderly, Geriatric pain, Injections, Interventional techniques, Kyphoplasty, Nerve blocks, Neuromodulation, Older adults, Opioids, Pain control, Pharmacotherapy, Seniors, Vertebroplasty",

author = "Christo, \{Paul J.\} and Sean Li and Gibson, \{Stephen J.\} and Perry Fine and Haroon Hameed",

note = "Funding Information: Disclosures P. J. Christo: none; S. Li: none. Dr. Stephen Gibson has received grants or has grants pending from the National Health and Medical Research Council (Australia). Dr. Perry Fine has served as a consultant for, and has received travel expense compensation from, Ameritox, Cephalon, Purdue Pharma, Meda Pharmaceuticals, King Pharmaceuticals, Eli Lilly and Co., and Forest Pharmaceuticals; has provided expert testimony for Johnson and Johnson and Cephalon; has received grants from the National Cancer Institute (USA); has received payment for the development of educational presentations from the National Initiative on Pain Control and the American Pain Foundation; and serves as President-Elect of the American Academy of Pain Medicine and on the board of directors of the American Pain Foundation. H. Hameed: none.",

year = "2011",

month = feb,

doi = "10.1007/s11916-010-0164-0",

language = "English (US)",

volume = "15",

pages = "22--34",

journal = "Current pain and headache reports",

issn = "1531-3433",

publisher = "Springer",

number = "1",

}

TY - JOUR

T1 - Effective treatments for pain in the older patient

AU - Christo, Paul J.

AU - Li, Sean

AU - Gibson, Stephen J.

AU - Fine, Perry

AU - Hameed, Haroon

N1 - Funding Information: Disclosures P. J. Christo: none; S. Li: none. Dr. Stephen Gibson has received grants or has grants pending from the National Health and Medical Research Council (Australia). Dr. Perry Fine has served as a consultant for, and has received travel expense compensation from, Ameritox, Cephalon, Purdue Pharma, Meda Pharmaceuticals, King Pharmaceuticals, Eli Lilly and Co., and Forest Pharmaceuticals; has provided expert testimony for Johnson and Johnson and Cephalon; has received grants from the National Cancer Institute (USA); has received payment for the development of educational presentations from the National Initiative on Pain Control and the American Pain Foundation; and serves as President-Elect of the American Academy of Pain Medicine and on the board of directors of the American Pain Foundation. H. Hameed: none.

PY - 2011/2

Y1 - 2011/2

N2 - By 2050, the number of older persons across the globe will exceed the number of younger people for the first time in history. Chronic conditions, especially pain, will rise in prevalence as the population ages. Controlling pain in this unique subset of the population demands careful attention to pharmacokinetic and pharmacodynamic factors and their specific impact on pharmacotherapies, relevant complementary and alternative medicine therapies, and interventional strategies.

AB - By 2050, the number of older persons across the globe will exceed the number of younger people for the first time in history. Chronic conditions, especially pain, will rise in prevalence as the population ages. Controlling pain in this unique subset of the population demands careful attention to pharmacokinetic and pharmacodynamic factors and their specific impact on pharmacotherapies, relevant complementary and alternative medicine therapies, and interventional strategies.

KW - Aging

KW - Analgesia

KW - Biopsychosocial

KW - Complementary and alternative medicine

KW - Elderly

KW - Geriatric pain

KW - Injections

KW - Interventional techniques

KW - Kyphoplasty

KW - Nerve blocks

KW - Neuromodulation

KW - Older adults

KW - Opioids

KW - Pain control

KW - Pharmacotherapy

KW - Seniors

KW - Vertebroplasty

UR - https://www.scopus.com/pages/publications/79551537896

UR - https://www.scopus.com/pages/publications/79551537896#tab=citedBy

U2 - 10.1007/s11916-010-0164-0

DO - 10.1007/s11916-010-0164-0

M3 - Article

C2 - 21128021

AN - SCOPUS:79551537896

SN - 1531-3433

VL - 15

SP - 22

EP - 34

JO - Current pain and headache reports

JF - Current pain and headache reports

IS - 1

ER -

Effective treatments for pain in the older patient

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this